Michael Koby

Gründer bei

1315 Capital LLC

53 Jahre

93 Beziehungen

Health Technology

Finance

Consumer Services

Profil

Mr. Michael Koby is a Founding Partner at 1315 Capital LLC.
He is on the Board of Directors at CHC Medical Partners, Inc., JDS Therapeutics LLC and Solsys Medical LLC.
Mr. Koby was previously employed as an Independent Director by Misonix, Inc., a Managing Director by Palm Ventures LLC, a Principal by Galen Collaborative Capital, a Principal by Medtronic, Inc., a Principal by Novoste Corp., and an Investment Banker by Dillon, Read & Co., Inc. He also served on the board at Soteira, Inc. He received his undergraduate degree from Cornell University and an MBA from The Wharton School of the University of Pennsylvania.

Aktive Positionen von Michael Koby

Unternehmen	Position	Beginn
JDS Therapeutics LLC JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops a portfolio of proprietary, clinically supported nutraceutical products focused around diabetes and related indications	Direktor/Vorstandsmitglied	-
1315 Capital LLC 1315 Capital LLC Investment ManagersFinance 1315 Capital invests in private companies located in the United States with revenues of USD 50 - 200 million. The firm focuses on companies operating in the fields of healthcare services, medical technology, medtech & pharma outsourcing and health & wellness companies. It provides financing for growth and buyout stage capital requirements with an investment size ranging from USD 15 to 50 million.	Gründer	01.05.2014
Solsys Medical LLC Solsys Medical LLC BiotechnologyHealth Technology Manufactures and distributes wound care products	Direktor/Vorstandsmitglied	-
CHC Medical Partners, Inc. CHC Medical Partners, Inc. Medical/Nursing ServicesHealth Services Provides health care services	Direktor/Vorstandsmitglied	-

Alle aktiven Positionen von Michael Koby

Ehemalige bekannte Positionen von Michael Koby

Unternehmen	Position	Ende
MISONIX, INC.	Direktor/Vorstandsmitglied	29.10.2021
Palm Ventures LLC Palm Ventures LLC Investment ManagersFinance Palm Ventures invests in both private and small public companies located in the United States. The firm targets companies operating in the fields of education, health & nutrition, financial equity and sustainability sectors. It provides financing for private investments, buyouts, early-stage companies and charitable investments.	Private Equity Investor	01.05.2014
Galen Management LLC Galen Management LLC Investment ManagersFinance Galen Management invests in companies located in the United States with revenues of USD 10 - 100 million and EBITDA of USD 0 - 9 million. The firm focuses on the health sector. It participates in growth capital requirements with an investment size of USD 10 - 100 million and also acquires minority or majority stakes.	Private-Equity-Analyst	16.06.2010
Medtronic, Inc. Medtronic, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for hypertension care	Corporate Officer/Principal	01.08.2003
Novoste Corp. Novoste Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products	Corporate Officer/Principal	31.12.2002

Sehen Sie sich die Erfahrung von Michael Koby im Detail an

Ausbildung von Michael Koby

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Michael Koby im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	13
Medtronic, Inc. Medtronic, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for hypertension care	Health Technology
Misonix, Inc. Misonix, Inc. Medical SpecialtiesHealth Technology Manufactures therapeutic ultrasonic medical devices	Health Technology
Novoste Corp. Novoste Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products	Health Technology
Solsys Medical LLC Solsys Medical LLC BiotechnologyHealth Technology Manufactures and distributes wound care products	Health Technology
Dillon, Read & Co., Inc. Dillon, Read & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services	Finance
Cornell University Cornell University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Galen Management LLC Galen Management LLC Investment ManagersFinance Galen Management invests in companies located in the United States with revenues of USD 10 - 100 million and EBITDA of USD 0 - 9 million. The firm focuses on the health sector. It participates in growth capital requirements with an investment size of USD 10 - 100 million and also acquires minority or majority stakes.	Finance
Soteira, Inc. Soteira, Inc. Medical SpecialtiesHealth Technology Develops surgical devices	Health Technology
CHC Medical Partners, Inc. CHC Medical Partners, Inc. Medical/Nursing ServicesHealth Services Provides health care services	Health Services
Palm Ventures LLC Palm Ventures LLC Investment ManagersFinance Palm Ventures invests in both private and small public companies located in the United States. The firm targets companies operating in the fields of education, health & nutrition, financial equity and sustainability sectors. It provides financing for private investments, buyouts, early-stage companies and charitable investments.	Finance
The Wharton School of the University of Pennsylvania The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
JDS Therapeutics LLC JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops a portfolio of proprietary, clinically supported nutraceutical products focused around diabetes and related indications	Health Technology
1315 Capital LLC 1315 Capital LLC Investment ManagersFinance 1315 Capital invests in private companies located in the United States with revenues of USD 50 - 200 million. The firm focuses on companies operating in the fields of healthcare services, medical technology, medtech & pharma outsourcing and health & wellness companies. It provides financing for growth and buyout stage capital requirements with an investment size ranging from USD 15 to 50 million.	Finance